These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1601604)

  • 61. Sequential measurements of glomerular filtration rate in conscious rats by a bolus injection of iodixanol and a single blood sample.
    Katayama R; Watanabe K; Yamagishi N; Abe S; Satoh H; Furuhama K
    J Appl Toxicol; 2011 May; 31(4):360-5. PubMed ID: 21259291
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Time dependence of iopamidol and iodixanol in arthrography of the knee.
    Carlier RY; Akeson P; Morvan G; Kristoffersen DT; Amar C; Vallée C
    Acta Radiol; 1999 Jan; 40(1):107-10. PubMed ID: 9973914
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The ACTIVE Trial: comparison of the effects on renal function of iomeprol-400 and iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography.
    Thomsen HS; Morcos SK; Erley CM; Grazioli L; Bonomo L; Ni Z; Romano L;
    Invest Radiol; 2008 Mar; 43(3):170-8. PubMed ID: 18301313
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Simplified procedure for the estimation of glomerular filtration rate following intravenous administration of iodixanol in cats.
    Katayama R; Saito J; Katayama M; Yamagishi N; Yamashita T; Kato M; Furuhama K
    Am J Vet Res; 2012 Sep; 73(9):1344-9. PubMed ID: 22924714
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Subclinical Contrast-Induced Acute Kidney Injury in Patients Undergoing Cerebral Computed Tomography.
    Breglia A; Godi I; Virzì GM; Guglielmetti G; Iannucci G; De Cal M; Brocca A; Carta M; Giavarina D; Ankawi G; Passannante A; Yun X; Biolo G; Ronco C
    Cardiorenal Med; 2020; 10(2):125-136. PubMed ID: 32036364
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pharmacokinetics of iopentol in the rat.
    Michelet AA; Skinnemoen K
    Acta Radiol Suppl; 1987; 370():101-4. PubMed ID: 2980301
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Contrast-induced nephropathy in outpatients with preexisting renal impairment: a comparison between intravenous iohexol and iodixanol.
    Cernigliaro JG; Haley WE; Adolphson DP; Jepperson MA; Crook JE; Thomas CS; Parker AS
    Clin Imaging; 2016; 40(5):902-6. PubMed ID: 27183138
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Contrast dose-to-creatinine clearance ratio as a potential indicator of risk for radiocontrast-induced nephropathy: correlation of D/CrCL with area under the contrast concentration-time curve using iodixanol.
    Sherwin PF; Cambron R; Johnson JA; Pierro JA
    Invest Radiol; 2005 Sep; 40(9):598-603. PubMed ID: 16118553
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Contrast medium-induced acute kidney injury: comparison of intravenous and intraarterial administration of iodinated contrast medium.
    Karlsberg RP; Dohad SY; Sheng R;
    J Vasc Interv Radiol; 2011 Aug; 22(8):1159-65. PubMed ID: 21570871
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Adverse skin reactions to iodinated x-ray contrast agents in healthy rats.
    Lenhard DC; May E; Morgenroth C; Jost G; Haider W; Pietsch H
    Invest Radiol; 2014 Dec; 49(12):779-87. PubMed ID: 24988006
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Bioanalytical methods for iodixanol and their application to studies on metabolism and protein binding.
    Jacobsen PB; Blindheim L; Skotland T
    Acta Radiol Suppl; 1995; 399():61-6. PubMed ID: 8610531
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Toxicity of iodixanol, a new nonionic iso-osmolar contrast medium, to rats by repeated intravenous administration for 4 weeks with a 4-week recovery period].
    Ohno H; Crome SJ; Furuhama K; Nomura M; Onodera T
    J Toxicol Sci; 1995 Oct; 20 Suppl 1():67-85. PubMed ID: 7490790
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A method for estimating the glomerular filtration rate in conscious monkeys.
    Satoh H; Nomiya N; Imai D; Sato S; Sakurai K; Takasuna K; Furuhama K
    J Appl Toxicol; 2016 Feb; 36(2):266-70. PubMed ID: 25994107
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparison of the effect of low- and iso-osmolar contrast agents on heart rate during chest CT angiography: results of a prospective randomized multicenter study.
    Chartrand-Lefebvre C; White CS; Bhalla S; Mayo-Smith WW; Prenovault J; Vydareny KH; Soto JA; Ozkan OS; Chughtai AR; Soulez G
    Radiology; 2011 Mar; 258(3):930-7. PubMed ID: 21212367
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Safety and pharmacokinetics of ioversol in healthy volunteers.
    Wilkins RA; Whittington JR; Brigden GS; Lahiri A; Heber ME; Hughes LO
    Invest Radiol; 1989 Oct; 24(10):781-8. PubMed ID: 2793391
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Dy-EOB-DTPA: tolerance and pharmacokinetics in healthy volunteers and preliminary liver imaging in patients.
    Krause W; Mahler M; Hanke B; Milius W; Kaufmann J; Rogalla P; Hamm B
    Invest Radiol; 2001 Aug; 36(8):431-44. PubMed ID: 11500593
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Investigation of binding of 125I-iodixanol to high molecular weight substances after incubation with rat liver homogenates.
    Jacobsen PB; Oulie I; Christiansen C; Skotland T
    Acta Radiol; 2001 Jan; 42(1):117-20. PubMed ID: 11167344
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparison of iodixanol and iohexol in patients undergoing intravenous pyelography: a prospective controlled study.
    Chuang FR; Chen TC; Wang IK; Chuang CH; Chang HW; Ting-Yu Chiou T; Cheng YF; Lee WC; Chen WC; Yang KD; Lee CH
    Ren Fail; 2009; 31(3):181-8. PubMed ID: 19288321
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Dose proportionality of iopromide pharmacokinetics and tolerability after i.v. injection in healthy volunteers.
    Krause W; Schuhmann-Giampieri G; Staks T; Kaufmann J
    Eur J Clin Pharmacol; 1994; 46(4):339-43. PubMed ID: 7957519
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [General pharmacological study of iodixanol, a new non-ionic isotonic contrast medium].
    Takasuna K; Kasai Y; Kitano Y; Mori K; Kobayashi R; Makino M; Hagiwara T; Hirohashi M; Nomura M; Algate DR
    J Toxicol Sci; 1995 Oct; 20 Suppl 1():133-51. PubMed ID: 7490785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.